A molecule would have the ability to reduce the neurological effects of binge drinking. This chemical compound could also be effective against neurodegenerative diseases such as Alzheimer’s.
A new treatment has been developed to cure the symptoms of “binge-drinking” (express biture in French), according to a published study in the Journal of Alcoholism and Drug Dependence. This molecule reduces the neurological effects (destruction of brain cells) and inflammation that result from heavy alcohol consumption.
In the long run, excessive alcohol consumption can lead to brain damage and trigger many symptoms, such as memory loss. The effects are particularly pronounced in adolescents, whose brains are developing.
Application for neurodegenerative diseases
Tested on rats subjected to a binge drinking diet, the chemical compound ethane-beta-sultam results in reduced nerve cell loss and inflammation in rodents.
The main novelty of this research is that ethane-beta-sultam can cross the brain’s blood-brain barrier, a brain defense mechanism that is also an impassable barrier for most treatments for neurological diseases. Beyond binge-drinking, the researchers therefore believe that their discovery could be used to fight against certain diseases such as Alzheimer’s, which result from a loss of brain activity.
.